Ovid Therapeutics Inc. (OVID) earnings
Quarterly results of Ovid Therapeutics Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Ovid Therapeutics Inc. reported revenue of $733K (-88.3% on the same quarter a year earlier) and a net loss of $15M.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $733K | -88.3% | -$15M | - |
| Q1 FY2026 | $0 | - | -$17M | - |
| Q4 FY2025 | $718K | +844.7% | $9.7M | - |
| Q3 FY2025 | $132K | -23.7% | -$12.2M | - |
| Q2 FY2025 | $6.3M | - | -$4.7M | - |
| Q1 FY2025 | $130K | - | -$10.2M | - |
| Q4 FY2024 | $76K | - | -$9.3M | - |
| Q3 FY2024 | $173K | - | -$14M | -$0.20 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
What were Ovid Therapeutics Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Ovid Therapeutics Inc. reported revenue of $733K and a net loss of $15M. The figures come from its filing with the SEC.
Is Ovid Therapeutics Inc.'s revenue growing?
Revenue in Q2 FY2026 was $733K, down 88.3% from $6.3M in the same quarter a year earlier.
Get an email when OVID reports
Follow OVID and we email you its next results the day they are filed, with the numbers explained.